# Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B

> **NCT01311947** · — · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 103 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT01311947
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2013-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311947, "Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01311947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*